Marquette General Cancer Center

 

Liver

 

Study Name - ECOG E1208

 

Study Description -

A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion.

 

IRB Open Date - 03/04/2011

 

Consent

 

Data Privacy Statement for Research Studies

 

 

<< Back